Stay updated on Pembrolizumab for Genomic Instability Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.

Latest updates to the Pembrolizumab for Genomic Instability Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe revision entry for the Study Protocol and Statistical Analysis Plan was updated from v3.6.5 to v3.6.6, indicating a newer version of the document is now linked on the study record.SummaryDifference0.1%

- Check22 days agoNo Change Detected
- Check36 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects a small maintenance update to the page metadata.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision line was updated to v3.6.4, indicating a software release rather than changes to study details. This appears to be a backend update without substantive changes to the trial information.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page now reflects a newer revision label (v3.6.3) replacing the previous one (v3.6.2), indicating an updated version of the study documents.SummaryDifference0.1%

- Check79 days agoChange DetectedUpdated Study Documents section now lists the Informed Consent Form (2022-05-11) and Study Protocol/Statistical Analysis Plan (2023-02-22), and adds IPD sharing information and expanded metadata/MeSH terms.SummaryDifference59%

- Check93 days agoChange DetectedThe page adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Study Plan header to Intervention/Treatment, while removing the older header spacing and bumping the revision version to v3.6.0. The recruitment status was changed to no longer recruiting, affecting enrollment availability.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Genomic Instability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Genomic Instability Clinical Trial page.